Presentations
Join BioPlan Associates as we explore the latest trends, insights, and expert opinions on biopharmaceutical manufacturing.
From Single-use systems, Outsourcing, Capacity constraints, and much more, these presentations dive into the most pressing issues and emerging opportunities in the industry, with data compiled from BioPlan’s Annual Report and of Biopharmaceutical Manufacturing Capacity and Production, the most comprehensive, longest-running study of bioprocessing professionals.
Upcoming Presentations
“Trends in Bio-Outsourcing and Onshoring Decisions” – October 22-23, 2026 at the Bethesda North Marriott in Rockville, MD. Key takeaway from Eric Langer, BioPlan Associates, Inc.
Participants of the BioPlan CDMO Challenges Survey presented at PBOA’s conference can receive an aggregated White Paper Summary. Contact BioPlan for more details.
Past Presentations
“The Biomanufacturing Capacity Crunch: Where CDMO Demand Is Still Outrunning Supply” – Contract Pharma Conference 2026, Sept 24, 2026. Key takeaway from Eric Langer, BioPlan Associates, Inc. Biopharma companies continue to rely on CDMOs for development and manufacturing support, but many sponsors still struggle to find the right capacity at the right time. Drawing on BioPlan’s latest industry survey data, this session will examine where capacity constraints remain most acute, including mammalian production, microbial fermentation, cell therapy and gene therapy. The presentation also highlighted what is driving the imbalance, how CDMOs are expanding, and why sponsors are looking beyond open manufacturing slots to evaluate flexibility, technical expertise, responsiveness and long-term fit.
Participants of the BioPlan CDMO Challenges Survey presented at Contract Pharma’s conference can receive an aggregated White Paper Summary. Contact BioPlan for more details.
“Economic Outlook and Trends in Life Sciences and Biotech” – BPSA Summit at Boston, July 27-29, 2026 – Key takeaway from Eric Langer, BioPlan Associates, Inc. “The industry is taking more strategic action—not waiting for uncertainty to clear. Organizations are shifting from reactive to proactive, data-driven decision-making, prioritizing manufacturing productivity while investing in automation and AI to drive the next era of biomanufacturing.”
“Adoption of Continuous Bioprocessing: CDMOs Lead the Way” – PBOA Annual Meeting & Conference 2025. Renaud Jacquemart, CEO, Omnium Global and Eric Langer presented.
“Biomanfacturing 2025: What’s Driving the Next Wave of Outsourcing Growth” – Contract Pharma’s 2025 Contracting and Outsourcing Conference, Sept 19, 2025, Hyatt Regency, Brunswick, NJ. Eric Langer, managing partner and president highlighting key trends shaping the future of our industry.
“Economic Outlook and Trends for the Single-Use Industry“– 2025 BPSA International Single-Use Summit, July 21-23, 2025, Four Seasons Hotel, Washington, DC. Eric Langer and Larry West, Publisher/Executive Editor, Aspen Alert, presented.